• Health & Medicine

Chemotherapy may boost immunotherapy power in ovarian cancer

Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy

15 June 2016

• Charity News

Cancer Research UK researchers honoured by the Queen

Two Cancer Research UK-funded experts have been recognised in the Queen’s Birthday Honours list for their services to science. Two Cancer Research UK-funded experts have been recognised in the Queen’s Birthday Honours list for their services to science.

11 June 2016

• Science & Technology

Acute myeloid leukaemia is 11 different diseases

Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms. Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms.

9 June 2016

• Health & Medicine

Bubbly drinks inspire more effective cancer treatment

Cancer Research UK scientists are developing a bubbly drink packed with oxygen microbubbles to make treatments more potent for hard to treat tumours. Cancer Research UK scientists are developing a bubbly drink packed with oxygen microbubbles to make treatments more potent for hard to treat tumours.

8 June 2016

• Health & Medicine

Staying on oestrogen-blocking drugs for five extra years 'prevents more breast cancers returning'

Women with the most common type of breast cancer could benefit from staying on key drugs for a decade, research suggests. Women with the most common type of breast cancer could benefit from staying on key drugs for a decade, research suggests.

6 June 2016

• Health & Medicine

New pre-surgery technique may make colostomy bags redundant for emergency bowel cancer patients

An expandable tube that unblocks the bowel before surgery could lead to fewer cancer patients – diagnosed as emergencies – needing a colostomy bag. An expandable tube that unblocks the bowel before surgery could lead to fewer cancer patients – diagnosed as emergencies – needing a colostomy bag.

5 June 2016

• Health & Medicine

Twice a day radiotherapy halves treatment time and is equally good at treating small cell lung cancer

Having radiotherapy once a day for six and a half weeks or twice a day for three weeks – with chemotherapy – is equally good at treating small cell lung cancer. Having radiotherapy once a day for six and a half weeks or twice a day for three weeks – with chemotherapy – is equally good at treating small cell lung cancer.

5 June 2016

• Science & Technology
• Health & Medicine

Defining cancers based on genetic ‘fingerprint’ could help personalise treatment

Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace. Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace.

4 June 2016

• Science & Technology
• Health & Medicine

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years. Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

3 June 2016

• Health & Medicine

NICE given grant to research patient preference

NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK. NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK.

2 June 2016

• Health & Medicine

Scientists tear down pancreatic cancer's defences

Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs. Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs.

2 June 2016